The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Stéphane Cook
Showing 1-19 of 19 articles
Long-term follow-up of an extreme kinking of a right coronary artery stenosis treated with a bioresorbable vascular scaffold
Stierlin F,
Puricel S,
Cook S
October 4, 2019 | 10.4244/EIJ-D-18-00441
Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials
Cassese S,
Byrne R,
Jüni P,
Wykrzykowska JJ,
Puricel S,
Ndrepepa G,
Schunkert H,
Fusaro M,
Cook S,
Kimura T,
Henriques J,
Serruys P,
Windecker S,
Kastrati A
January 19, 2018 | 10.4244/EIJ-D-17-00492
Switzerland: coronary and structural heart interventions from 2010 to 2015
Rigamonti F,
Fahrni G,
Maeder M,
Cook S,
Weilenmann D,
Wenaweser P,
Rothlisberger C,
Corti R,
Rickli H,
Kaiser C,
Roffi M
May 15, 2017 | 10.4244/EIJ-D-16-00828
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction
Pilgrim T,
Piccolo R,
Heg D,
Roffi M,
Tüller D,
Vuilliomenet A,
Muller O,
Cook S,
Weilenmann D,
Kaiser C,
Jamshidi P,
Khattab A,
Taniwaki M,
Rigamonti F,
Nietlispach F,
Blochlinger S,
Wenaweser P,
Jüni P,
Windecker S
December 9, 2016 | 10.4244/EIJY15M12_09
Will ABSORB III change my practice? Everolimus-eluting bioresorbable scaffolds for coronary artery disease
Cook S,
Nef H,
Capodanno D,
Tamburino C,
Baumbach A
August 20, 2016 | 10.4244/EIJV12I6A130
Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trial
Franzone A,
Taniwaki M,
Rigamonti F,
Heg D,
Piccolo R,
Roffi M,
Tüller D,
Muller O,
Vuilliomenet A,
Cook S,
Weilenmann D,
Kaiser C,
Jamshidi P,
Jüni P,
Windecker S,
Pilgrim T
August 5, 2016 | 10.4244/EIJV12I5A99
A propensity score-matched comparison between Cardia and Amplatzer PFO closure devices - insights from the SOLUTION registry (Swiss percutaneOus patent foramen ovale cLosUre in recurrent clinical events prevenTION)
Puricel S,
Arroyo D,
Goy J-J,
Praz F,
Palhais N,
Wahl A,
Stauffer J-C,
Togni M,
Berger A,
Meier B,
Cook S
June 19, 2015 | 10.4244/EIJY14M05_05
Five-year results of a randomised comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularisation
Pilgrim T,
Räber L,
Limacher A,
Wenaweser P,
Cook S,
Stauffer J-C,
Garachemani A,
Moschovitis A,
Meier B,
Jüni P,
Windecker S
March 20, 2015 | 10.4244/EIJY15M01_04
Long-term comparison of everolimus-eluting and biolimus-eluting stents
Puricel S,
Oberhänsli M,
Guntern P,
Lehmann S,
Goy J-J,
Arroyo D,
Villeneuve H,
Baeriswyl G,
Stauffer J-C,
Togni M,
Cook S
July 26, 2013 | 10.4244/EIJV9I3A55
A modified technique of balloon anchoring for tricky stent delivery
Aeby G,
Surmely J-F,
Togni M,
Cook S
January 18, 2013 | 10.4244/EIJV8I9A168
Sealing pseudo-aneurysms of the femoral artery with saline injection: a new technique
Périard D,
Meyer M-A,
Hayoz D,
Cook S
February 21, 2012 | 10.4244/EIJV7I10A192
Clinical outcomes after PCI for acute coronary syndrome in unprotected left main coronary artery disease: insights from the Swiss Acute Left Main Coronary Vessel Percutaneous Management (SALVage) study
Puricel S,
Adorjan P,
Oberhänsli M,
Stauffer J-C,
Moschovitis A,
Vogel R,
Goy J-J,
Muller O,
Eeckhout E,
Togni M,
Wenaweser P,
Meier B,
Windecker S,
Cook S
October 28, 2011 | 10.4244/EIJV7I6A112
Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound study
Eshtehardi P,
Cook S,
Wandel S,
Räber L,
Wenaweser P,
Togni M,
Vogel R,
Garachemani A,
Eberli F,
Lüscher T,
Jüni P,
Hess O,
Meier B,
Windecker S
September 30, 2010
Percutaneous coronary interventions in Europe in 2006
Moschovitis A,
Cook S,
Meier B
June 30, 2010 | 10.4244/EIJV7I6A31
Elective implantation of sirolimus-eluting stents for bifurcated and non-bifurcated unprotected left main coronary artery lesions: clinical outcomes at one year
Barragan P,
Fajadet J,
Sheiban I,
Serruys P,
Colombo A,
Seabra-Gomes R,
Goy J-J,
Cook S,
Rubino P,
Lefèvre T
August 20, 2008
Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-DELFT)
Meliga E,
Garcia-Garcia H,
Valgimigli M,
Chieffo A,
Biondi-Zoccai G,
O’ Maree A,
Gonzalo N,
Cook S,
Cruz-González I,
Marra S,
De Servi S,
Palacios I,
Windecker S,
van Domburg R,
Colombo A,
Sheiban I,
Serruys P
May 13, 2008
Have we been misled by the ESC DES firestorm?
Cook S,
Meier B
March 20, 2008
Percutaneous coronary interventions in Europe in 2005
Praz L,
Cook S,
Meier B
January 20, 2008
Percutaneous coronary interventions in Europe 1992-2003
Cook S,
Togni M,
Walpoth N,
Maier W,
Muehlberger V,
Legrand V,
Milicic D,
Zambartas C,
Zelízko M,
Madsen J-K,
van Buuren F,
López-Palop R,
Peeba M,
Koskenkorva J,
Vanhanen H,
Lablanche J,
Lazaris I,
Géza F,
Eyjolfsson K,
Kearney P,
Piscione F,
Erglis A,
Navickas R,
Beissel J,
Channam R,
Koch K,
Deleanu D,
Melberg T,
Witkowski A,
Pereira H,
Reho I,
Fridrich V,
Zorman D,
Nilsson T,
Oezmen F,
Ludman P,
Meier B
February 20, 2006
1
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke